Last reviewed · How we verify

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust — Portfolio Competitive Intelligence Brief

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Botulinum Toxin-A injection Botulinum Toxin-A injection marketed Neurotoxin; neuromuscular blocking agent SNARE complex (specifically cleaves SNAP-25) Neurology; Orthopedics; Aesthetics

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Ivo Pitanguy Institute · 1 shared drug class
  2. Lanzhou Institute of Biological Products Co., Ltd · 1 shared drug class
  3. University of Utah · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust:

Cite this brief

Drug Landscape (2026). Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/robert-jones-and-agnes-hunt-orthopaedic-and-district-nhs-trust. Accessed 2026-05-17.

Related